Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut microbiota changes after Helicobacter pylori eradication
ChiCTR2000029940Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Apr 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole, amoxicillin, bismuth subcitrate and clarithromycin in Helicobacter pylori infection (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: gut microbiota. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
esomeprazoleamoxicillinbismuth subcitrateclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2000029940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029940.